What was tested
He, Liang, Zhao, and colleagues at Guangxi Medical University report in Tissue & Cell that Notoginsenoside R1 (NGR1), a saponin from Panax notoginseng, promotes odontogenic differentiation of human dental pulp stem cells (hDPSCs) and improves reparative dentin in a dog direct-pulp-capping model (He et al. 2026, abstract). The work spans in vitro hDPSC assays and an in vivo adult-dog study. It is a laboratory and animal study, not a human trial. We could not read the publisher full text: ScienceDirect returned a bot challenge on every route, and no PubMed Central or Europe PMC full-text mirror is available. The claims below are therefore limited to what the PubMed/MEDLINE abstract and Europe PMC metadata verify, with no figure numbers, exact sample sizes, or p-values.
In vitro: concentration and markers
The authors treated hDPSCs with NGR1 at 0, 50, 100, and 200 micrograms per milliliter and measured proliferation (CCK-8), migration (Transwell), and odontogenic differentiation by alkaline phosphatase (ALP) and Alizarin Red S staining, plus RT-PCR for ALP and DSPP (He et al. 2026, abstract, Methods). NGR1 increased proliferation, migration, and mineralized nodule formation. Both 100 and 200 micrograms per milliliter significantly promoted mineralization. RT-PCR showed ALP and DSPP mRNA upregulated in NGR1-treated groups. The authors identify 100 micrograms per milliliter as the concentration that gives the best balance between proliferation and pro-differentiation effects (same source, Results/Conclusion).
That concentration framing matters. A higher dose is not simply better: 200 micrograms per milliliter also raised mineralization, but the authors’ chosen headline concentration is 100 micrograms per milliliter because it balanced cell growth with differentiation. The ALP and DSPP signals are gene-expression and enzyme markers, not structured dentin. Alizarin Red S staining shows mineral deposition in culture, a proxy for odontogenic activity. These are encouraging but still dish-level results.
In vivo: adult dog direct pulp capping
The animal arm used adult dogs in a direct pulp capping model. The experimental group received a 100 micrograms per milliliter NGR1 rinse before capping; samples were taken at 1, 4, 8, and 12 weeks. Both control and NGR1-treated teeth formed continuous, uniform, and thickened reparative dentin over time, and H&E staining showed dentin bridges at 4, 8, and 12 weeks in both groups (He et al. 2026, abstract, Results). The difference was structural, not presence versus absence: the NGR1 group’s reparative dentin appeared to have more numerous, regularly arranged dentinal tubules and a more compact architecture, whereas the control group looked less organized.
This is the honest boundary of the in vivo claim. NGR1 did not create reparative dentin where none existed; the control teeth also bridged. It improved the microstructural quality of the repair. That is still a meaningful result for the pulp-dentin repair program (/programs/pulp-dentin-repair/), but it should not be read as “NGR1 regenerated dentin” in a binary sense.
The transcriptomic lead
RNA-Seq of hDPSCs treated with 100 micrograms per milliliter NGR1 identified 50 upregulated differentially expressed genes. The dentin-related gene S100A9 was among them. Enrichment analysis pointed to complement and coagulation cascades, cytokine-cytokine receptor interaction, Staphylococcus aureus infection, and tuberculosis pathways. Protein-protein interaction analysis flagged SPRR1A, SPRR1B, and SPRR3 as potential hub proteins, and RT-PCR and immunohistochemistry confirmed the sequencing trends (He et al. 2026, abstract, Results).
S100A9 is an inflammation- and mineralization-associated calcium-binding protein; SPRR genes are small proline-rich proteins linked to epithelial and stress responses. The authors frame these as repair-related pathways that may guide future mechanistic work. What is not established is whether any of these genes are necessary for the NGR1 effect, or whether they are downstream correlates. The abstract offers them as a basis for future studies, and that is how we should treat them.
What it does not show
This is not a human clinical result, not a randomized trial, and not a comparison against existing pulp capping materials such as mineral trioxide aggregate or calcium hydroxide. The in vivo model is adult dogs, not people. The in vitro work uses a single cell type at defined concentrations, and the mechanism is inferred from transcriptomics and pathway enrichment rather than from targeted rescue or knockout experiments. The paper also does not test whether NGR1 is stable, safe, or practical in a clinical pulp-capping formulation. Any downstream claim that a notoginseng extract can replace standard pulp therapy runs well ahead of the data.
Where we differ from the coverage
We found no popular or press coverage of this paper to differ from. It is a niche laboratory report less than a week post-publication. The caution worth stating is against compressing the abstract into “a Chinese herb regrows tooth dentin.” The actual result is more specific: a defined saponin improved the quality of reparative dentin in dogs and shifted cultured human pulp stem cells toward odontogenic markers, with a 100 micrograms per milliliter concentration looking like the most balanced dose. The state-of-the-field summary at /field/ does not change on this paper. Useful next steps would be a dose-response in the dog model, a head-to-head comparison with an approved pulp-capping material, and functional experiments that test whether S100A9 or the SPRR hub proteins are required for the NGR1 effect.
Provenance: grounded in the MEDLINE/PubMed abstract for PMID 42612582 and Europe PMC metadata for DOI 10.1016/j.tice.2026.103858; the publisher full text was bot-walled and not read, so no figures, exact sample sizes, or statistics are claimed. Method and sourcing standard at /method/.